T
Tango Therapeutics, Inc.
TNGX · NASDAQ · Healthcare · 4.2B
Closing price
$23.81
+5.49% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
8.0×
Enterprise value / EBITDAEV/EBITDA
-27.1×
Free cash flow yieldFCF yield
-5.1%
Return on equityROE
-29.3%
Operating margin
-178.4%
Net debt / EBITDAbalance-sheet strength
0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.